{
    "nctId": "NCT02011815",
    "briefTitle": "Exploring Biological Linkage Between Circadian Disruption and Cancer Progression",
    "officialTitle": "A Prospective Study of Exploring Possible Biological Linkage Between Circadian Disruption and Cancer Progression",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 236,
    "primaryOutcomeMeasure": "Progression-free survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age: 18-70\n* Breast cancer patients who are getting chemotherapy for the first time in life\n* Patients are either having stage 4 cancer or starting neoadjuvant chemotherapy.\n* Patient have signed on the informed consent, and well understood the objective and procedure of this study\n\nExclusion Criteria:\n\n* Patients already have received chemotherapy\n* Patient had another cancer (except thyroid cancer) within 5 years\n* Patient with severe medical condition\n* Patient had taken psychiatric medication more than 1 month in life\n* Patient worked the night shift for more than 1 month in 6 months",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}